DK0464140T3 - Aktivt adhæsionspeptid - Google Patents

Aktivt adhæsionspeptid

Info

Publication number
DK0464140T3
DK0464140T3 DK90905829.9T DK90905829T DK0464140T3 DK 0464140 T3 DK0464140 T3 DK 0464140T3 DK 90905829 T DK90905829 T DK 90905829T DK 0464140 T3 DK0464140 T3 DK 0464140T3
Authority
DK
Denmark
Prior art keywords
peptides
biologically active
domain
hydrophobic
hydrophobic domain
Prior art date
Application number
DK90905829.9T
Other languages
English (en)
Inventor
Cyril J Honsik
Michael D Pierschbacher
Lisa B Dreisbach
Original Assignee
Jolla Cancer Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Cancer Res Found filed Critical Jolla Cancer Res Found
Application granted granted Critical
Publication of DK0464140T3 publication Critical patent/DK0464140T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/06—Peptides being immobilised on, or in, an organic carrier attached to the carrier via a bridging agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Dental Preparations (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90905829.9T 1989-03-20 1990-03-20 Aktivt adhæsionspeptid DK0464140T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/326,168 US5120829A (en) 1989-03-20 1989-03-20 Hydrophobic attachment site for adhesion peptides

Publications (1)

Publication Number Publication Date
DK0464140T3 true DK0464140T3 (da) 1994-09-05

Family

ID=23271081

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90905829.9T DK0464140T3 (da) 1989-03-20 1990-03-20 Aktivt adhæsionspeptid

Country Status (9)

Country Link
US (4) US5120829A (da)
EP (1) EP0464140B1 (da)
JP (1) JP2723669B2 (da)
AT (1) ATE109161T1 (da)
CA (1) CA2046631A1 (da)
DE (1) DE69011102T2 (da)
DK (1) DK0464140T3 (da)
ES (1) ES2057553T3 (da)
WO (1) WO1990011297A1 (da)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843156A (en) 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
US5575815A (en) * 1988-08-24 1996-11-19 Endoluminal Therapeutics, Inc. Local polymeric gel therapy
US5654267A (en) * 1988-12-20 1997-08-05 La Jolla Cancer Research Center Cooperative combinations of ligands contained within a matrix
US5120829A (en) * 1989-03-20 1992-06-09 La Jolla Cancer Research Foundation Hydrophobic attachment site for adhesion peptides
DE69126871T2 (de) * 1990-04-06 1998-03-12 Jolla Cancer Res Found Verfahren und verbindung zur behandlung von thrombose
JP2620727B2 (ja) 1990-10-26 1997-06-18 富士写真フイルム株式会社 ペプチド脂質
JP2620729B2 (ja) 1990-11-30 1997-06-18 富士写真フイルム株式会社 ペプチド誘導体
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
US5468494A (en) * 1993-11-12 1995-11-21 Aphton Corp. Immunogenic compositions against human gastrin 17
US5656441A (en) * 1994-04-19 1997-08-12 Trustees Of Boston University Methods for determining cellular adhesion
US5843741A (en) * 1994-08-01 1998-12-01 Massachusetts Insitute Of Technology Method for altering the differentiation of anchorage dependent cells on an electrically conducting polymer
US5750370A (en) * 1995-06-06 1998-05-12 Human Genome Sciences, Inc. Nucleic acid encoding human endothlein-bombesin receptor and method of producing the receptor
US5677276A (en) * 1994-12-23 1997-10-14 La Jolla Cancer Research Foundation Immobilization of peptides to hyaluronate
DE19505070C2 (de) * 1995-02-15 1997-03-27 Axel Prof Dr Med Haverich Künstliche Gefäßsysteme und Verfahren zu ihrer Herstellung
US5874165A (en) * 1996-06-03 1999-02-23 Gore Enterprise Holdings, Inc. Materials and method for the immobilization of bioactive species onto polymeric subtrates
CA2287872C (en) * 1997-05-12 2010-07-27 Aphton Corporation Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors
CA2328501A1 (en) * 1998-05-15 1999-11-25 Aphton Corporation Prevention and treatment of hypergastrinemia
US20030068326A1 (en) * 1998-05-15 2003-04-10 Aphton Corporation Method for the treatment of gastroesophageal reflux disease
US6428579B1 (en) * 1998-07-01 2002-08-06 Brown University Research Foundation Implantable prosthetic devices coated with bioactive molecules
US6277824B1 (en) * 1998-07-10 2001-08-21 Adherex Technologies Compounds and methods for modulating adhesion molecule function
BR0009804A (pt) * 1999-04-16 2002-04-16 Childrens Medical Center Peptìdeos moduladores de adesão e seus usos
US6689165B2 (en) 2000-03-31 2004-02-10 Board Of Supervisors Of Louisana State University And Agricultural And Mechanical College Surface modifications for enhanced epithelialization
US7078021B2 (en) 2000-08-16 2006-07-18 Acologix, Inc. Dental products comprising bone growth enhancing peptide
US6911425B2 (en) * 2000-08-16 2005-06-28 Acologix, Inc. Integrin binding motif containing peptides and methods of treating skeletal diseases
JP2005508838A (ja) * 2001-03-23 2005-04-07 アフトン コーポレーション 膵癌の組合せ治療
US20090191232A1 (en) * 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
AU2002326356A1 (en) * 2001-07-09 2003-01-29 Aphton Corporation Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus
US6810583B2 (en) * 2001-08-07 2004-11-02 International Business Machines Corporation Coupling of conductive vias to complex power-signal substructures
US20110009960A1 (en) * 2001-11-16 2011-01-13 Allergan, Inc. Prosthetic fabric structure
US6902932B2 (en) * 2001-11-16 2005-06-07 Tissue Regeneration, Inc. Helically organized silk fibroin fiber bundles for matrices in tissue engineering
GB0209893D0 (en) * 2002-04-30 2002-06-05 Molmed Spa Conjugate
GB0209896D0 (en) * 2002-04-30 2002-06-05 Molmed Spa Conjugate
US20060020119A1 (en) * 2004-03-29 2006-01-26 Stephen Grimes Monoclonal antibodies to gastrin hormone
WO2004088326A2 (en) * 2003-03-28 2004-10-14 Aphton Corporation Gastrin hormone immunoassays
EP1794586B1 (en) 2004-09-22 2013-01-30 Cancer Advances, Inc., Monoclonal antibodies to progastrin
US7622438B1 (en) 2005-07-18 2009-11-24 Acologix, Inc. Protein formulation for promoting hard tissue formation
GB2433506A (en) * 2005-12-20 2007-06-27 Sharp Kk A method of producing a multimeric capture agent
GB2433591A (en) * 2005-12-20 2007-06-27 Sharp Kk Method for functionalising a hydrophobic substrate
GB2433505A (en) * 2005-12-20 2007-06-27 Sharp Kk Capture agents for binding a ligand
CN101240030B (zh) * 2007-02-07 2010-08-11 首都医科大学 正十一烷基和rgd肽构建的缀合物、它们的合成及在医学中的应用
CN101240027B (zh) * 2007-02-07 2011-04-20 首都医科大学 正壬烷基和rgd肽构建的缀合物、它们的合成及在医学中的应用
CN101240028B (zh) * 2007-02-07 2010-08-18 首都医科大学 正十五烷基和rgd肽构建的缀合物、它们的合成及在医学中的应用
CN101240029B (zh) * 2007-02-07 2010-08-11 首都医科大学 正庚烷基和rgd肽构建的缀合物、其合成方法和应用
CN101240031B (zh) * 2007-02-07 2010-10-13 首都医科大学 正十七烷基和rgd肽构建的缀合物、其制备方法及应用
US8529897B2 (en) 2007-08-16 2013-09-10 Carnegie Mellon University Inflammation-regulating compositions and methods
US20090246248A1 (en) * 2008-03-27 2009-10-01 Affinergy Coating compositions having improved performance
US9308070B2 (en) * 2008-12-15 2016-04-12 Allergan, Inc. Pliable silk medical device
CN105063875A (zh) 2008-12-15 2015-11-18 阿勒根公司 制造用于假体装置的编织网的方法
US9326840B2 (en) 2008-12-15 2016-05-03 Allergan, Inc. Prosthetic device and method of manufacturing the same
US9204954B2 (en) * 2008-12-15 2015-12-08 Allergan, Inc. Knitted scaffold with diagonal yarn
US9204953B2 (en) 2008-12-15 2015-12-08 Allergan, Inc. Biocompatible surgical scaffold with varying stretch
US20110052695A1 (en) * 2009-04-20 2011-03-03 Allergan, Inc. Drug delivery platforms comprising silk fibroin hydrogels and uses thereof
US20110189292A1 (en) * 2009-04-20 2011-08-04 Allergan, Inc. Dermal fillers comprising silk fibroin hydrogels and uses thereof
US20110111031A1 (en) * 2009-04-20 2011-05-12 Guang-Liang Jiang Drug Delivery Platforms Comprising Silk Fibroin Hydrogels and Uses Thereof
ES2443045T5 (es) * 2009-04-20 2021-05-10 Allergan Inc Hidrogeles de fibroína de seda y usos de éstos
CA2773956A1 (en) * 2009-09-11 2011-03-17 Allergan, Inc. Prosthetic device and method of manufacturing the same
US12150978B2 (en) 2017-06-15 2024-11-26 Cancer Advances Inc. Compositions and methods for preventing tumors and cancer
KR102772810B1 (ko) 2017-06-15 2025-02-28 캔서 어드밴시스 아이엔씨 종양 및 암에 대한 체액성 및 세포 면역을 유도하기 위한 조성물 및 방법
WO2019176860A1 (ja) * 2018-03-15 2019-09-19 東レ株式会社 細胞接着性材料

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2288105A1 (fr) * 1974-10-14 1976-05-14 Ajinomoto Kk Proteines fixees biologiquement actives, et leur procede de preparation
WO1984000540A1 (en) * 1982-08-04 1984-02-16 Jolla Cancer Res Found Polypeptide
US4578079A (en) * 1982-08-04 1986-03-25 La Jolla Cancer Research Foundation Tetrapeptide
US4792525A (en) * 1982-08-04 1988-12-20 La Jolla Cancer Research Foundation Tetrapeptide
EP0134307B1 (de) * 1983-07-29 1989-04-19 Henning Berlin GmbH Chemie und Pharmawerk Voraktivierte Kunststoffoberflächen zur Immobilisierung von organisch-chemischen und biologischen Materialien, Verfahren zur Herstellung und Verwendung derselben
EP0142193A1 (en) * 1983-10-22 1985-05-22 Akzo N.V. Preparation of immunogens consisting of antigens and/or antigenic determinants bound to glycoside-containing carriers
US4687820A (en) * 1984-08-22 1987-08-18 Cuno Incorporated Modified polypeptide supports
US4923802A (en) * 1985-06-13 1990-05-08 Immunex Corporation Peptide substrates for the detection, characterization and purification of protein kinase C
DE3546150A1 (de) * 1985-06-24 1987-01-22 Hoechst Ag Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
US4683291A (en) * 1985-10-28 1987-07-28 Scripps Clinic And Research Foundation Platelet binding inhibitors
US4804650A (en) * 1986-10-28 1989-02-14 Biotechnology Research Associates, J.V. Analogs of atrial natriuretic peptides
US5352664A (en) * 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
US5120829A (en) * 1989-03-20 1992-06-09 La Jolla Cancer Research Foundation Hydrophobic attachment site for adhesion peptides

Also Published As

Publication number Publication date
CA2046631A1 (en) 1990-09-21
US5760176A (en) 1998-06-02
WO1990011297A1 (en) 1990-10-04
EP0464140A1 (en) 1992-01-08
JP2723669B2 (ja) 1998-03-09
US5591822A (en) 1997-01-07
ES2057553T3 (es) 1994-10-16
JPH04506511A (ja) 1992-11-12
US5587456A (en) 1996-12-24
DE69011102T2 (de) 1994-11-24
ATE109161T1 (de) 1994-08-15
DE69011102D1 (de) 1994-09-01
EP0464140B1 (en) 1994-07-27
US5120829A (en) 1992-06-09

Similar Documents

Publication Publication Date Title
ATE109161T1 (de) Hydrophobe bindungsstelle für adhäsionspeptide.
CS239980A2 (en) Zpusob vyroby peptidu
DE69227041D1 (de) Expression und reinigung von rekombinantem, löslichem gewebefaktor
DE69425464D1 (de) Polysaccharidderivat und wirkstoffträger
CA2050336A1 (en) Yeast processing system comprising a negatively charged amino acid adjacent to the processing site
ATE204300T1 (de) Zielzellen-bindende chimäre peptide
SE9301172D0 (sv) Foerfarande foer framstaellning av en peptidalkohol
PT1288223E (pt) Derivados de peptidos terapeuticos
DE69604147D1 (de) Flüssige zuzammensetzung zur stabilisierung von aminosäure-herbiziden
ATE81135T1 (de) Aktive thymopentin-analoga.
ES2141164T3 (es) Compuestos amfifilicos derivados de aminoacidos o de peptidos, sus metodos de sintesis y su aplicacion como sistemas de transporte de farmacos.
RU94046091A (ru) Полипептидные антагонисты бомбезина, фармацевтическая композиция и способ лечения
ES2038233T3 (es) Liquidos acondicionadores de substancia dental y osea.
DE69520475D1 (de) Pharmaceutische Zusammensetzung von biologisch aktiven Peptiden oder Proteinen
MY106287A (en) Acid addition salts of amidated taurine or glycine, their preparation and use
NZ504486A (en) Attaching substances to micro-organisms
EP0082568A3 (en) Retro-inverso analogues of c-terminal penta and hexapeptides of substance p.
IE902389L (en) Enzymatically binding bioactive materials to proteins
ZA943920B (en) Pharmaceutical compositions
DE69315730D1 (de) Verfahren zur Herstellung von Peptiden und neue Zwischenverbindungen dazu
ATE129744T1 (de) Rekombinantes c-terminal alpha amidatierungsenzym von menschlischem thyroidursprung.
DE3665462D1 (en) Pharmacologically active peptides
Pierschbacher et al. Hydrophobic attachment site for adhesion peptides
DK661888A (da) Biologisk aktive molekyler
IT8203588A0 (it) Procedimento per la racemizzazione di alfa aminoacidi otticamente attivi